Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Daniel A. Nikcevich

Hematology | Oncology
Essentia Health
The Duluth Clinic Ltd
400 E 3rd St, Duluth Ssb6, 
Duluth, MN 
Accepting New Patients
Offers Telehealth

Advanced in WT1-Related Wilms Tumor Syndromes
Essentia Health
The Duluth Clinic Ltd
400 E 3rd St, Duluth Ssb6, 
Duluth, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Nikcevich is a Hematologist and an Oncologist in Duluth, Minnesota. Dr. Nikcevich is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Large-Cell Immunoblastic Lymphoma, Richter Syndrome, and Angiosarcoma. Dr. Nikcevich is currently accepting new patients.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in MN
Hospital Affiliations
Essentia Health St Mary's Medical Center
Essentia Health Deer River
Essentia Health Virginia
Essentia Health Duluth
St Marys Hospital Superior
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Itasca Medical Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

THE DULUTH CLINIC LTD
400 E 3rd St, Duluth Ssb6, Duluth, MN 55805
Call: 218-786-8364
Other Locations
THE DULUTH CLINIC LTD
420 E 1st St, Duluth, MN 55805
Call: 218-786-8364

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Drug
Study Phase: Phase 3
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug, Other, Procedure
Study Drugs: Clofarabine, Daunorubicin, Cytarabine, Decitabine
Study Phase: Phase 3
View 1 Less Clinical Trial

18 Total Publications

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network.
Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2024
View All 18 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Randall E. Millikan
Oncology | Hematology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Randall E. Millikan
Oncology | Hematology
400 E 3rd St, Essentia Health Duluth Clinic, 
Duluth, MN 
 (0.1 miles away)
218-786-3625
Languages Spoken:
English
See accepted insurances

Randall Millikan is an Oncologist and a Hematologist in Duluth, Minnesota. Dr. Millikan is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Prostate Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Adult Soft Tissue Sarcoma.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Bret E. Friday
Oncology | Hematology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Bret E. Friday
Oncology | Hematology

The Duluth Clinic Ltd

400 E 3rd St, Duluth Ssb6, 
Duluth, MN 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bret Friday is an Oncologist and a Hematologist in Duluth, Minnesota. Dr. Friday is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Adenocarcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer (NSCLC), Breast Cancer, and Endoscopy. Dr. Friday is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Anne C. Silva-Benedict
Hematology Oncology | Hematology | Oncology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Anne C. Silva-Benedict
Hematology Oncology | Hematology | Oncology

St. Luke's Hospital Of Duluth

1015 E 1st St, 
Duluth, MN 
 (0.6 miles away)
218-249-7860
Languages Spoken:
English, Sinhala
See accepted insurances
Accepting New Patients
Offers Telehealth

Anne Silva-Benedict is a Hematologist Oncology specialist and a Hematologist in Duluth, Minnesota. Dr. Silva-Benedict is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Silva-Benedict is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nikcevich's expertise for a condition
ConditionClose
    • Distinguished
    • Angiosarcoma
      Dr. Nikcevich is
      Distinguished
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Nikcevich is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Large-Cell Immunoblastic Lymphoma
      Dr. Nikcevich is
      Distinguished
      . Learn about Large-Cell Immunoblastic Lymphoma.
      See more Large-Cell Immunoblastic Lymphoma experts
    • Lung Adenocarcinoma
      Dr. Nikcevich is
      Distinguished
      . Learn about Lung Adenocarcinoma.
      See more Lung Adenocarcinoma experts
    • Richter Syndrome
      Dr. Nikcevich is
      Distinguished
      . Learn about Richter Syndrome.
      See more Richter Syndrome experts
    • Small Cell Lung Cancer (SCLC)
      Dr. Nikcevich is
      Distinguished
      . Learn about Small Cell Lung Cancer (SCLC).
      See more Small Cell Lung Cancer (SCLC) experts
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Nikcevich is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Autoimmune Hemolytic Anemia
      Dr. Nikcevich is
      Advanced
      . Learn about Autoimmune Hemolytic Anemia.
      See more Autoimmune Hemolytic Anemia experts
    • Breast Cancer
      Dr. Nikcevich is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Chromophobe Renal Cell Carcinoma
      Dr. Nikcevich is
      Advanced
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Nikcevich is
      Advanced
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    • Colorectal Cancer
      Dr. Nikcevich is
      Advanced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    View All 31 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Nikcevich is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Nikcevich is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Nikcevich is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Nikcevich is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adenoid Cystic Carcinoma
      Dr. Nikcevich is
      Experienced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Adult Immune Thrombocytopenia
      Dr. Nikcevich is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    View All 141 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved